Research & Development
Innovation to fuel growth is at the top of the R & D agenda. The pharmaceutical industry continues to go through significant changes that present both challenges and opportunities for R & D. There are increasing pressures to reduce costs, to launch new products as patents expire, and to improve compliance in a world of ever-changing regulatory complexity.
As a result, many companies are responding by developing bold, transformational R & D strategies as they set the stage for future success. They are also finding new ways to measure and improve, to increase lab productivity, to ensure compliance with regulatory requirements, and to accelerate clinical trials.
TayganPoint Consulting Group knows and understands your world, and we’re ready to combine forces. We help develop and implement transformational regulatory strategies and processes to manage partnerships, accelerate clinical trials, leverage CRO’s and improve collaboration with regulatory bodies to ensure compliance and timely registrations. Pre- and post- merger and acquisition, our team leads time-sensitive integration of regulatory, clinical and organizational processes.
We deliver research and development renewal.
- Is your regulatory strategy aligned globally with clinical, research, supply chain and commercialization operations?
- Do you have the right information and data to make effective strategic decisions at various stage gates throughout R & D?
- Is your clinical strategy effectively balanced between internal and external resources?
Operations and Execution
- Is your entire organization aligned around the end-to-end regulatory process? For example, are regulatory registrations aligned with supply chain and inventory management?
- Are your Regulatory operations effectively managed from local, regional and global perspectives?
- Is your lab productivity measured and utilized to drive continuous operational improvements?
- Do you have the right mix of near-shore, CRO outsourcing and internal operations for optimal clinical effectiveness?
Global Pharmaceutical Company After a major acquisition, TayganPoint helped manage and integrate regulatory functions. Processes and information were developed to close gaps, eliminate bottlenecks and ensure timely regulatory compliance.
Pre-Eminent Global Pharmaceutical Research Company TayganPoint re-engineered the end-to-end regulatory process, processes integrating across the business and regulatory areas. Operations were optimized for global, regional and local effectiveness.
F100 Global Pharmaceutical Company Overall clinical and operational processes were assessed, identifying near-shore and outsourcing opportunities to optimize clinical efficiencies.